Intratumoral administration of poly‐<scp>ICLC</scp> enhances the antitumor effects of anti‐<scp>PD</scp>‐1
Combination therapy with poly-ICLC, especially through IT route, and anti-PD-1 provides significantly greater antitumor effects than anti-PD-1 monotherapy in syngeneic mouse models of HCC.
Authors
- Shin‐Yun Liu (ORCID: https://orcid.org/0000-0003-3120-6848)
- Jin‐Chuan Sheu (ORCID: https://orcid.org/0000-0002-2503-7139)
- Meng‐Tzu Weng (ORCID: https://orcid.org/0000-0002-4143-6607)
- Shih‐Feng Yang (ORCID: https://orcid.org/0000-0002-0156-0953)
- Chia‐Lang Hsu (ORCID: https://orcid.org/0000-0002-7447-8045)
- Mei–Hsuan Lee (ORCID: https://orcid.org/0000-0002-8017-0434)
Institutions
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Journal of Hepato-Biliary-Pancreatic Sciences
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1002/jhbp.12088
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Taiwan University Hospital